## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.8% in lower entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (0.7%) confirms momentum alignment. Caution: momentum weakening (-2.3% MRS), overbought RSI (71).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($45.08)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 6)

**1. Freeport-McMoRan Inc. (NYSE:FCX) Declares Quarterly Dividend of $0.08**
- Source: MarketBeat | 20251218T013136 | Bullish | Relevance: 100%
- Freeport-McMoRan Inc. (NYSE:FCX) has declared a quarterly dividend of $0.075 per share, payable on February 2nd to shareholders of record on January 15th, with an ex-dividend date of January 15th. This represents an annualized dividend of $0.30 and a yield of 0.6%, which is well-covered by earnings with a payout ratio of about 13.6%. The company recently beat earnings estimates and analysts have a positive outlook with an average price target of $49.11.

**2. Securities Fraud Class Action Filed Against Freeport-McMoRan Inc. (FCX) - Levi & Korsinsky Reminds Investors of January 12, 2026**
- Source: PHL17.com | 20251217T180753 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a securities class action lawsuit against Freeport-McMoRan Inc. (FCX) on behalf of investors who purchased securities between February 15, 2022, and September 24, 2025. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures at its Grasberg Block Cave mine, leading to heightened regulatory, litigation, and reputational risks. Investors are reminded of the January 12, 2026, deadline to seek potential recovery under federal securities laws.

**3. Kuehn Law Encourages Investors of Freeport-McMoran Inc. to Contact Law Firm**
- Source: TMX Newsfile | 20251217T151024 | Bearish | Relevance: 100%
- Kuehn Law, PLLC is investigating whether officers and directors of Freeport-McMoran Inc. (NYSE: FCX) breached their fiduciary duties to shareholders. A federal securities lawsuit alleges the company misrepresented or failed to disclose safety issues at its Grasberg Block Cave mine in Indonesia. Investors who purchased FCX prior to February 15, 2022, are encouraged to contact the firm.

**4. Freeport-McMoRan declares $0.15 per share dividend for February**
- Source: Investing.com | 20251217T130823 | Bullish | Relevance: 100%
- Freeport-McMoRan Inc. (NYSE:FCX) announced a cash dividend of $0.15 per share, payable on February 2, 2026, to shareholders of record as of January 15, 2026. This dividend, split into base and variable components, yields 0.63% and follows a strong 26.75% year-to-date return for FCX. The company recently reported better-than-expected Q3 2025 earnings and is planning to restore large-scale operations at its Grasberg Block Cave.

**5. Freeport-McMoRan declares $0.15 per share dividend for February By Investing.com**
- Source: Investing.com South Africa | 20251217T124659 | Bullish | Relevance: 100%
- Freeport-McMoRan Inc. announced a cash dividend of $0.15 per share, comprising a base and a variable component, payable on February 2, 2026, to shareholders of record as of January 15, 2026. This dividend follows the company's strong performance, including a 26.75% year-to-date return and better-than-expected Q3 2025 earnings, leading analysts to reiterate positive ratings and adjust price targets. The company is also planning to restore large-scale operations at its Grasberg Block Cave in Q2 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.2x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.21 signals overvaluation risk, limited margin of safety. Forward P/E 21.2x attractive for 48% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 2 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $68.8B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.21 |
| Forward P/E | 21.2 |
| Current P/E | 31.3 |
| YoY Growth | 47.7% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 6.1% to 3.8% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 71, risk of mean reversion. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.76% (CS: 89) | Strong |
| RSI_14 | 71.1 | Overbought |
| MACD Histogram | 0.33 | Bullish |
| vs SMA20 | 1.078x | Above |
| vs SMA50 | 1.130x | Above |
| vs SMA200 | 1.170x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $47.94
- **Stop Loss:** $45.08 (6.0% risk)
- **Target:** $52.23 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 398
- **Position Value:** $19,080.12
- **Portfolio %:** 19.08%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*